Aurobindo
Swami Iyer is the CFO of North America for Aurobindo. Swami has over 25 years of experience in finance and accounting. Prior to joining Aurobindo, they were the Senior Director of Finance and Information Technology for Aurolife Pharma LLC. Swami has also worked for various other companies in finance and accounting roles.
Iyer has a Bachelor's degree in Commerce from the University of Madras and is a Certified Public Accountant (CPA). Swami is a member of the American Institute of CPAs (AICPA) and the Institute of Chartered Accountants of India (ICAI).
After completing their AICPA, Swami Iyer worked in accounting, auditing, and taxation for several years before pursuing their MBA at Osmania University. Swami's focus in finance and banking has helped him develop a strong understanding of the financial industry.
This person is not in any offices
Aurobindo
6 followers
Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs). Its product portfolio is spread over seven therapeutic/product areas, including antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterologicals, anti-allergies and anti-diabetics. It is engaged in developing a range of oncology and hormonal products. It is also developing inhalation and dermatology products, such as pressurized metered-dose inhaler (pMDI). It markets its products through chain stores in the United States. It has developed over three injectable penem products. The Company, through its subsidiary, manufactures and sells nutritional supplements. It has over 10 manufacturing units and approximately two research and development centers. The Company, in addition to marketing its products domestically, also markets its products globally in over 150 countries.